Tag: Health Care

Displaying 21 - 40 of 1006 results.

Pages

Valeant Pharmaceuticals, the parent of Bausch + Lomb, agreed to sell Paragon Holdings I, Inc. to settle charges that its May 2015 acquisition of Paragon reduced competition for the sale of FDA-approved buttons used for three types of gas permeable, or GP, lenses: orthokeratology...
“The FTC is pleased that the 7th Circuit rejected the district court’s geographic market findings, and we are looking forward to proving our case,” said Debbie Feinstein, Director of the FTC’s Bureau of Competition.
Brief of the Federal Trade Commission in support of a petition for rehearing and rehearing en banc and urging the court to clarify or amend its September 28, 2016, decision in the case. The brief urges the court to (1) clarify the decision so it cannot be read to limit the kinds of...
At a public hearing in Abingdon, Virginia, held today, FTC staff presented oral remarks to the Southwest Virginia Health Authority and the Virginia Department of Health summarizing staff’s analyses and conclusions that the cooperative agreement application submitted by Mountain States Health...
FTC staff submitted a comment to the Southwest Virginia Health Authority and the Virginia Department of Health opposing the cooperative agreement application submitted by Mountain States Health Alliance and Wellmont Health System. “The proposed merger presents substantial risk of...
Brief of the United States Department of Justice and the Federal Trade Commission as amici curiae, urging the Fifth Circuit to dismiss the appeal for lack of jurisdiction or, if the Court finds jurisdiction, to reject application of the state action doctrine to this case because the...
On September 9, 2016, the Federal Trade Commission and Department of Justice filed a joint amicus brief urging the U.S. Court of Appeals for the Fifth Circuit to dismiss an appeal by the Texas Medical Board of a district court decision holding that Board regulations restricting telehealth services...
The Federal Trade Commission will participate in a Twitter chat hosted by the Centers for Disease Control. The chat will include tips about healthy contact lens wear and care habits. The FTC will explain consumers’ rights under the Contact Lens Rule, including the right to get your prescription...
FTC staff submitted a comment to the Delaware Board of Dietetics/Nutrition regarding its proposed telehealth regulation that would require in-person initial evaluations of patients, and then allow licensed dietitians and nutritionists to determine whether to use telehealth thereafter...
Federal Trade Commission staff submitted a comment to the Delaware Board of Dietetics/Nutrition regarding its proposed telehealth regulation that would require in-person initial evaluations of patients, and then allow licensed dietitians and nutritionists to determine whether to use telehealth...
After a public comment period, the Federal Trade Commission has approved a final order resolving the Commission’s complaint against Practice Fusion. In its complaint, the FTC charged that Practice Fusion misled consumers by soliciting reviews for doctors in connection with an online healthcare...
Beginning in 1997, the Food and Drug Administration (FDA) allowed television advertisements to make major statements about a prescription drug, while referring to detailed drug information on the internet (FDA 1997; 2015). The hope was that consumers would seek additional information...
FTC staff submitted a comment to the Delaware Board of Occupational Therapy Practice on its proposed regulation that would likely facilitate the provision of occupational therapy services to Delaware consumers. The proposed regulation would allow licensed occupational therapists (OT...
Federal Trade Commission staff submitted a comment to the Delaware Board of Occupational Therapy Practice on its proposed regulation that would likely facilitate the provision of occupational therapy services to Delaware consumers.
Mylan Inc. agreed to divest the rights and assets related to two generic pharmaceutical products in order to settle FTC charges that its proposed $7.2 billion acquisition of Swedish drug maker Meda would be anticompetitive. The FTC order preserves competition in the markets for 250...
Teva Pharmaceutical Industries Ltd. agreed to sell the rights and assets related to 79 pharmaceutical products to settle FTC charges that its proposed $40.5 billion acquisition of Allergan plc’s generic pharmaceutical business would be anticompetitive. The remedy requires Teva to...

Pages